BP announces gas production from third stage of WND in Egypt
The British multinational oil and gas company BP plc has announced gas production from third stage of West Nile Delta (WND) development which is off the mediterranean cost in Egypt.
With approximately $9 billion, The development of WND includes five gas fields across the north Alexadria, West Mediterranean Deepwater offshore concession blocks in the Mediterranean Sea.
The oil company and its partners, working with the ministry of petroleum, have developed the WND in three stages.
The Chief Executive Officer of BP, Bernard Looney, said:
“Completing this major multi-stage development in the face of many challenges is testament to bp’s long-term commitment to Egypt and our excellent working relationships with partners and the Government.
“West Nile Delta will make an important contribution to meeting Egypt’s growing energy needs, by providing a cost-competitive and resilient gas supply from the country’s own resources.”
The gas production Raven Field follows Taurus/Libra and Giza/Fayoum projects which started production in the year 2017 and 2019 respectively, which helps in producing gas to a new onshore processing facility, alongside the existing West Nile Delta onshore processing plant.
The Raven field which currently produces approximately 600 million standard cubic feet of gas per day (mmscf/d). At its peak, Raven field has the potential to produce 900 mmscf/d and around 30,000 barrels per day of condensate.
The development of WND includes 25 wells producing gas to the onshore processing plant via three long-distance subsea tie-backs.
Including the Raven field, the onshore facilities now have 1.4 billion standard cubic feet of gas processing capacity per day.
The oil and gas company has invested in sustainable local community development projects, through out different phases of the project, it has also maximised local content created thousands of jobs, directly and indirectly for Egyptian citizens.
BP has 82.75% of stake in the West Nile Delta development, while Wintershall Dea holds rest of the 17.25% interest.